Categories
Health

British Airways agrees to require unfavorable coronavirus exams earlier than New York flights, Cuomo says

British Airways Boeing 747-400, nicknamed the Queen of the Skies airliner, on final landing gear landing at New York’s JFK John F. Kennedy International Airport, USA on January 23, 2020.

Nicolas Economou | NurPhoto | Getty Images

British Airways will require travelers to test negative for coronavirus before boarding flights to New York’s John F. Kennedy International Airport, New York Governor Andrew Cuomo said on Monday as officials grappled with a highly contagious new strain of Covid -19 grapple that is spreading the UK

Cuomo said at a press conference that he had also asked Delta Air Lines and Virgin Atlantic to adhere to the same requirements.

“We know what the governor said and will work with his office to understand the exact details New York State is looking for regarding flights out of the UK,” said a Delta spokesman. Virgin and British Airways did not immediately respond to a request for comment.

More than two dozen countries have blocked flights or access to people from the UK due to the new strain of the virus.

U.S. and overseas airlines have already suspended much of their international service due to Covid-19 and travel restrictions. For example, since March the US has banned most foreigners in the European Union or the UK from entering.

There are 122 flights between the UK and the US this week, up from 752 last year, according to flight data provider OAG.

Categories
Business

On Brexit and Coronavirus, Boris Johnson Leaves It Late

This undermined the government’s goal of curbing social contacts in the face of a new variant of the coronavirus that British officials said is spreading far faster than the original strain. In fact, the refugees from London are likely to spread the virus across the country, where 35,928 new cases were reported on Sunday.

It is more tactical when the Prime Minister pulls out a post-Brexit deal. With only 10 days to go before December 31st, there would be very little time for a review of an agreement in parliament, where pro-Brexit hardliners would keep a close eye on it. But with no margin for error, analysts say Mr Johnson may have to compromise to prevent an economically ruinous breakdown in talks.

“The outlines of a possible deal have been known at least since last March,” said Sam Lowe, trade expert at the Center for European Reforms. “But the prime minister’s approach is to take difficult decisions until the last minute in the hope that something better will happen – as his approach to Covid-19 shows.”

Tim Bale, Professor of Politics at Queen Mary University in London, said: “The price for this psychological flaw and its political consequences is paid in lost lives in the case of Covid. In Brexit, livelihoods could be lost if some companies go under due to the uncertainty caused by the delay in decision-making. “

With the UK less than two weeks away from leaving the single market and customs union, UK businesses still have no idea whether their goods will be subject to tariffs when they are exported to continental Europe or Ireland. That could make car factories unprofitable or put some farmers out of business.

Trade talks continued in Brussels on Sunday with no sign of a breakthrough. The two sides are mostly haggling over fishing rights, but there are signs that Mr Johnson is already bowing to the European Union’s broader demand for Britain to accept long-term restrictions on its competition policy and state aid to industry.

Regarding the pandemic, critics say Mr. Johnson’s scattershot policies have undermined public confidence in the government. He has ruled out bans repeatedly, only to reverse course on the claim that the scientific evidence has changed. The mixed messages have left many confused and cynical about the rules.

In the recent U-turn, Mr Johnson cited new evidence that the variant was up to 70 percent more transmissible than the original virus – data he said was presented to his cabinet on Friday. Independent scholars generally have concerns about the variant. But UK health officials said Sunday that they first identified the variant in October from a sample taken in September.

Updated

Apr. 20, 2020 at 2:37 am ET

The government first announced the variant last Monday – and feared it could spread faster – when it placed London and other parts of southern and eastern Britain in the then highest levels of restrictions. Two days later, Mr. Johnson reiterated his promise to relax the December 23-27 restrictions so families can get together for Christmas.

When the leader of the opposition Labor Party, Keir Starmer, proposed in Parliament that Mr Johnson reconsider this plan, the Prime Minister ridiculed him. “I wish he had the courage just to say what he really wanted to do,” said Mr Johnson, “which means canceling the plans people have made and canceling Christmas.”

Now, of course, the prime minister has done just that – only he waited three more days with more people making travel plans. On Sunday, the Netherlands, Belgium, Italy, France, Germany and Austria began banning flights from the UK while the European Union weighed a coordinated response.

Mr Starmer predictably faded into criticism, saying that Mr Johnson was “so afraid of being unpopular that he won’t be able to make difficult decisions until it’s too late”.

The Prime Minister had given a glimpse into his fears earlier this week when he alluded to Oliver Cromwell holding Christmas celebrations during the ascetic days of the Puritan movement in England in the mid-17th century. The British newspapers, which had set Cromwell’s precedent in recent weeks, wasted no time in tagging Mr. Johnson with it after announcing the Christmas ban.

Surprisingly, the tough measures themselves may not be unpopular. A poll by research firm YouGov following Mr Johnson’s announcement on Saturday found that 67 percent of those polled were in favor of additional restrictions. But 61 percent of people said the government handled the rollout poorly.

According to analysts, Mr Johnson has been pressured by the same lawmakers in his Conservative Party that are likely to oppose a trade deal with the European Union. In this respect, the pandemic and the Brexit talks have a connection.

Because his mismanagement of the lockdown rules has angered some conservative lawmakers, they could now calculate that he can’t afford any further backlash in parliament by concluding a trade deal with the European Union that would be unpopular with die-hard Brexiters.

Mr Johnson has navigated swarms like this during his political career. His deadline mentality, developed during his time as a newspaper reporter and columnist, has sometimes led to smart decisions.

For example, he wavered for weeks before endorsing Britain’s exit from the European Union and even writing essays discussing both sides of the subject. It was a roll of the dice that pays off if it gives him a path to Downing Street.

Overall, analysts continue to assume that Mr Johnson will come to terms with the European Union in the next few days. By leaving the final decision so late, the Prime Minister has increased the likelihood that, as with the Christmas lockdown, he will have no choice but to accept the offer on the table.

“Johnson’s technique for dealing with problems is to get them out of control and build them to a point of sufficient crisis where delay is no longer sustainable,” wrote Rafael Behr in a column for The Guardian. “That way, it becomes perversely easier to choose because there are fewer options.”

Categories
Health

The Coronavirus Is Mutating. What Does That Imply for Us?

Just as vaccines were beginning to offer hope for a way out of the pandemic, British officials issued an urgent warning on Saturday of a so-called highly contagious new variant of the coronavirus circulating in England.

Citing the rapid spread of the virus in London and the surrounding area, Prime Minister Boris Johnson imposed the country’s strictest lockdown since March. “If the virus changes its method of attack, we will have to change our method of defense,” he said.

A similar version of the virus has emerged in South Africa, which appears to share some of the mutations seen in the British variant. This virus was found in 90 percent of the samples whose genetic sequences were analyzed in South Africa.

Scientists are concerned about these variants, but not surprised by them. Researchers have found thousands of tiny changes in the genetic material of the coronavirus that has hopped around the world.

Some variants become more common in a population only through luck, not because the changes somehow charge the virus. However, because vaccinations and increased immunity make it harder for the pathogen to survive in human populations, researchers also expect the virus to acquire beneficial mutations that make it easier to spread or evade detection by the immune system.

“It’s a real warning that we need to take a closer look,” said Jesse Bloom, evolutionary biologist at the Fred Hutchinson Cancer Research Center in Seattle. “Certainly these mutations will spread, and definitely the scientific community. We need to monitor these mutations and characterize their effects.”

The British variant has around 20 mutations, including several that affect how the virus binds to and infects human cells. These mutations could allow the variant to replicate and transmit more efficiently, said Muge Cevik, an infectious disease expert at the University of St Andrews in Scotland and a scientific advisor to the UK government.

The estimate of higher transferability – British officials said the variant was up to 70 percent more transferable – is based on the modeling and has not been confirmed in laboratory experiments, added Dr. Cevik added.

“Overall, I think we need a little more experimental data,” she said. “We cannot completely rule out that some of this portability data is related to human behavior.”

In South Africa, too, scientists quickly discovered that human behavior triggered the epidemic, not new mutations whose effects on transmissibility had yet to be quantified.

The UK announcement also raised concerns that the virus could evolve to become resistant to the vaccines that are being rolled out. The concerns focus on a few changes in the viral genetic code that may make it less susceptible to certain antibodies.

However, several experts warned caution, saying it would take years – not months – for the virus to develop to the point where current vaccines become impotent.

“Nobody should worry that there will be a single catastrophic mutation that will suddenly make all immunity and antibodies unusable,” said Dr. Bloom.

“It will be a process that takes place over a period of several years and requires the accumulation of multiple viral mutations,” he added. “It’s not going to be like an on-off switch.”

Like all viruses, the coronavirus is a shape shifter. Some genetic changes are unimportant; others can give him an advantage.

Scientists fear the latter possibility, in particular: vaccinating millions of people can put tremendous pressure on the virus to become resistant to the immune response, pushing back the global battle for years.

There are already small changes in the virus that have occurred independently of one another several times around the world, suggesting that the mutations are helpful for the pathogen. The mutation The affect on antibody susceptibility – technically known as the 69-70 deletion, which means that letters are missing from the genetic code – has been observed at least three times: in Danish mink, in humans in the UK, and in an immunocompromised patient who became much less sensitive to convalescent plasma .

“This thing transmits, it acquires, it keeps adapting,” said Dr. Ravindra Gupta, a virologist at the University of Cambridge, who last week detailed the recurring genesis and spread of the deletion. “But people don’t want to hear what we’re saying, namely: this virus is going to mutate.”

The new genetic deletion changes the spike protein on the surface of the coronavirus that it needs to infect human cells. Variants of the virus with this deletion appeared independently in Thailand and Germany in early 2020 and were distributed in Denmark and England in August.

Scientists initially thought the new coronavirus was stable and unlikely to escape a vaccine-induced immune response, said Dr. Deepti Gurdasani, a clinical epidemiologist at Queen Mary University in London.

“But in the last few months it has become very clear that mutations can occur,” she said. “As selection pressure increases with mass vaccination, these mutants will likely appear more frequently.”

Several recent publications have shown that the coronavirus can evolve to avoid detection by a single monoclonal antibody, a cocktail of two antibodies, or even a convalescent serum given to a particular individual.

Fortunately, the body’s entire immune system is a much more formidable enemy.

The Pfizer-BioNTech and Moderna vaccines induce an immune response only to the spike protein that the coronavirus carries on its surface. But every infected person produces a large, unique and complex repertoire of antibodies against this protein.

“The fact is you have a thousand great guns aimed at the virus,” said Kartik Chandran, a virologist at Albert Einstein College of Medicine in New York. “No matter how the virus turns and weaves, it is not that easy to find a genetic solution that can really fight all of these different antibody specificities, let alone the other arms of the immune response.”

In short, it will be very difficult for the coronavirus to escape the body’s defenses, despite the many variations it can take.

To escape immunity, a virus has to accumulate a series of mutations that allow the pathogen to undermine the effectiveness of the body’s defenses. Some viruses, such as influenza, accumulate these changes relatively quickly. But others, like the measles virus, hardly collect changes.

Even the influenza virus takes five to seven years to collect enough mutations to completely evade immune recognition, noted Dr. Bloom. His lab released a new report on Friday showing that cold coronaviruses also evolve to evade immune recognition – but over many years.

The extent of the infections in this pandemic can quickly lead to diversity in the new coronavirus. Still, a vast majority of people around the world have yet to become infected, and that has given scientists hope.

“It would be a little surprising to me if we saw active selection for immune escape,” said Emma Hodcroft, a molecular epidemiologist at the University of Bern in Switzerland.

“In a population that is still largely naive, the virus just doesn’t have to do that yet,” she said. “But it’s something we want to look out for in the long term, especially when we get more people vaccinated.”

Immunizing about 60 percent of the population within a year and reducing the number of cases along the way can help minimize the chance of a significant mutation in the virus, said Dr. Hodcroft.

Still, scientists need to closely track the developing virus to identify mutations that could give it an advantage over vaccines.

Scientists routinely monitor mutations in flu viruses to update vaccines and should do the same for the coronavirus, said Trevor Bedford, evolutionary biologist at the Fred Hutchinson Cancer Research Center in Seattle.

“You can imagine that there is a similar process for the flu vaccine where you swap out these variants and everyone gets their annual covid shot,” he said. “I think that will be necessary in general.”

The good news is that the technology used in Pfizer-BioNTech and Moderna’s vaccines is much easier to customize and update than traditional vaccines. The new vaccines also generate a massive immune response so the coronavirus may need many mutations over the years before vaccines need to be tweaked, said Dr. Bedford.

In the meantime, the Centers for Disease Control and Prevention and other government agencies should set up a national system to link viral sequence databases to on-site data – for example, whether an infection has occurred despite vaccination.

“These are useful suggestions for scientists and governments to put systems in place – now before we could need them, especially when we start vaccinating people,” said Dr. Hodcroft. “But the public shouldn’t necessarily panic.”

Categories
Politics

Authorities shutdown looms as Congress crafts coronavirus stimulus invoice

U.S. Senate Majority Leader Mitch McConnell, Republican of Kentucky, walks to his office from the Senate at the U.S. Capitol in Washington, DC on December 18, 2020.

Saul Loeb | AFP | Getty Images

Congress dangerously neared the government shutdown as lawmakers failed to put the finishing touches on Friday on a massive spending and coronavirus bailout package.

Before midnight Friday to pass a spending bill, the House put in place a two-day emergency bill to keep the government going. Legislators gave themselves roughly seven and a half hours to get it through both houses of Congress, including a Senate where a member’s objection can block its swift passage.

Heads of state and government on Capitol Hill have said for days that they are on the verge of reaching an agreement on a $ 900 billion aid proposal that would cost $ 1.4 trillion in spending. However, some new disputes have prevented Washington from sending new aid to warring Americans for the first time in nearly nine months.

On Friday afternoon, it seemed like a challenge to reach an agreement on a huge spending and pandemic relief plan, let alone keep government spending from deteriorating. While bipartisan House representatives, including minority leader Kevin McCarthy, R-Calif., Endorse the temporary funding bill, the Senate will pose bigger problems.

Passing a temporary spending measure known as a rolling resolution “could prove quite difficult,” Senate Republican No. 2 Republican John Thune of South Dakota told reporters Friday. To quickly approve the move, the Senate would need the support of every Senator. A handful of lawmakers have proposed halting the passage of a short-term spending bill.

Thune also signaled it could take days to iron out a definitive coronavirus relief package as millions of Americans await help.

“It comes together, it just takes time, but it’s slower,” he said. “And you know, I think we have to assume that even if a deal is announced, we will work through the weekend if it is written and edited.”

Just after 2 p.m. ET on Friday, House Majority Leader Steny Hoyer, D-Md., Said the Chamber would be on hiatus until 5 p.m. while congressional leaders try to get a “clearer picture” of how to move forward . He urged representatives to keep Friday evenings, Saturday and Sunday free.

If the legislature can approve an expenditure calculation before Monday, the damage would be limited by a failure of federal funding.

The leaders of Congress have pledged to work through the weekend and pass a bill before heading home for the vacation. The health and livelihood of millions of Americans depend on Congress sending more aid before the end of the year.

Just hours earlier, Senate Majority Leader Mitch McConnell, R-Ky. described an agreement as imminent.

“The talks remain productive,” said McConnell on Friday morning. “In fact, I am now even more optimistic than last night that a non-partisan two-chamber framework for a major rescue package is very close.”

With healthcare workers receiving Covid-19 vaccinations during a crushing wave of infections across the country, federal funding is required for further distribution of the shots. The outbreak has killed more than 310,000 people nationwide as the US struggles to contain its spread.

Meanwhile, 12 million people will lose unemployment insurance the day after Christmas if Congress doesn’t extend the pandemic provisions that expanded benefits. If a federal eviction moratorium expires at the end of the month, millions are at risk of losing their homes.

While the developing $ 900 billion relief plan is designed to expand these unemployment benefits, it is currently unclear how it will address evacuation protection and any assistance to those who owe rent.

The proposal is expected to reintroduce a federal unemployment insurance surcharge of $ 300 per week. A federal payment of $ 600 a week introduced in March expired in the summer, dropping revenues by millions.

The package would include direct payments of $ 600, although it’s unclear who is eligible to receive them. Families are expected to receive $ 600 for children as well. Progressives in Congress and some Republicans have labeled the sum too low for people to come by during the pandemic, finding that lawmakers easily approved a direct payment of $ 1,200 in March.

White House advisors have stopped President Donald Trump from sending last-minute checks for up to $ 2,000 to Americans, the Washington Post reported Thursday.

Senator Josh Hawley, R-Mo., Attempted to approve a measure that would allow another direct payment of $ 1,200 on Friday. He called the injection of cash “the least we can do for working families”.

Senator Ron Johnson, R-Wisc., Then objected to passing the measure on public debt concerns, arguing that tax cuts and deregulation would better serve Americans who are out of work during the pandemic. It is unclear how these measures would help people find it difficult to afford food and housing now.

The exchange highlighted the challenges that Congress will face in the coming days in both preventing a shutdown and passing a bailout package. Johnson even called the $ 900 billion package, which contains only $ 600 checks, “way too big”.

Hawley said he would block a short-term government funding bill unless he saw a final aid proposal that included direct payments.

Senator Bernie Sanders, I-Vt., Attempted to pass a proposal that would send $ 1,200 in direct payments later Friday afternoon. The Senator, backed by Senate Minority Chairman Chuck Schumer, DN.Y., said, “In this time of crisis, it’s funny that our Republican friends are finding again that we are in deficit.”

Johnson disagreed again.

The Congressional relief plan would include at least $ 300 billion in small business support. It would also provide funding for the distribution and testing of Covid-19 vaccines and provide relief to hospitals.

The proposal would put money in schools and the transport sector.

A handful of problems sparked the final phase of negotiations. This includes a Federal Emergency Management Agency relief fund for states and restrictions. Senator Pat Toomey, R-Pa., Wants to strengthen the Federal Reserve’s emergency lending powers during the pandemic, according to NBC News.

Senator Elizabeth Warren, D-Mass., Said Republicans who support the provision “sabotage” President-elect Joe Biden’s ability to lead an economic recovery after taking office on Jan. 20.

“Proposals to sabotage President Biden and our nation’s economy are ruthless, false and have no place in this legislation,” she said in a statement.

In a later statement, the Chairs of House Financial Services and the Ways and Means Committee said an agreement was “in sight” before the GOP pushed for an “unacceptable provision”.

“The extreme Senate Republican call threatens to derail this much-needed move and it must be abandoned immediately so we can move forward,” said MPs Maxine Waters, D-Calif., And Richard Neal, D-Mass Statement.

A Toomey spokesperson did not immediately respond to CNBC’s request to comment on Democratic criticism.

Congress passed the $ 2 trillion CARES bill in late March, which provides solid economic support in the early stages of the pandemic. But lawmakers did not offer any new help in the months that followed, despite the ravages of the virus, financial lifelines falling by the wayside, and cracks in the economic recovery.

Democrats have pushed for significantly more relief. Calling the $ 900 billion plan a “down payment,” Biden has signaled that he will attempt to approve further aid after he takes office on Jan. 20.

McConnell pushed for new spending of only about $ 500 billion for months. Many in his party resisted putting so much money into a relief plan.

Next year, Democrats are likely to push for new aid to state and local governments who may have to lay off first responders when faced with budget crises. The GOP did not agree to send the relief without corporate liability coverage.

The leaders of Congress agreed to set both issues aside in negotiating the year-end package.

– CNBC’s Kayla Tausche contributed to this report

Subscribe to CNBC on YouTube.

Categories
Health

A European Official Reveals a Secret: The U.S. Is Paying Extra for Coronavirus Vaccines

This is significantly lower than the company’s official price, which was announced at $ 19.50 per dose, which the US government has also paid. The Pfizer vaccine launch began this week in the United States.

The Moderna vaccine, which is the next to be approved for the EU on January 6 and is expected to receive emergency approval by the U.S. Food and Drug Administration on Friday, costs the EU $ 18 per dose, as the table shows. The company said it would charge $ 25 to $ 37 per dose. The US government was directly involved in funding the development of the Moderna vaccine and has signed a contract to pay around $ 15 per dose.

Covid19 vaccinations>

Answers to your vaccine questions

With a coronavirus vaccine spreading out of the US, here are answers to some questions you may be wondering about:

    • If I live in the US, when can I get the vaccine? While the exact order of vaccine recipients may vary from state to state, most doctors and residents of long-term care facilities will come first. If you want to understand how this decision is made, this article will help.
    • When can I get back to normal life after the vaccination? Life will only get back to normal once society as a whole receives adequate protection against the coronavirus. Once countries have approved a vaccine, they can only vaccinate a few percent of their citizens in the first few months. The unvaccinated majority remain susceptible to infection. A growing number of coronavirus vaccines show robust protection against disease. However, it is also possible that people spread the virus without knowing they are infected because they have mild symptoms or no symptoms at all. Scientists don’t yet know whether the vaccines will also block the transmission of the coronavirus. Even vaccinated people have to wear masks for the time being, avoid the crowds indoors and so on. Once enough people are vaccinated, it becomes very difficult for the coronavirus to find people at risk to become infected. Depending on how quickly we as a society achieve this goal, life could approach a normal state in autumn 2021.
    • Do I still have to wear a mask after the vaccination? Yeah, but not forever. Here’s why. The coronavirus vaccines are injected deep into the muscles and stimulate the immune system to produce antibodies. This seems to be sufficient protection to protect the vaccinated person from disease. What is not clear, however, is whether it is possible for the virus to bloom in the nose – and sneeze or exhale to infect others – even if antibodies have been mobilized elsewhere in the body to prevent that vaccinated person gets sick. The vaccine clinical trials were designed to determine if people who were vaccinated are protected from disease – not to find out if they can still spread the coronavirus. Based on studies of flu vaccines and even patients infected with Covid-19, researchers have reason to hope that people who are vaccinated will not spread the virus, but more research is needed. In the meantime, everyone – including those who have been vaccinated – must imagine themselves as possible silent shakers and continue to wear a mask. Read more here.
    • Will it hurt What are the side effects? The vaccine against Pfizer and BioNTech, like other typical vaccines, is delivered as a shot in the arm. The injection in your arm feels no different than any other vaccine, but the rate of short-lived side effects seems to be higher than with the flu shot. Tens of thousands of people have already received the vaccines, and none of them have reported serious health problems. The side effects, which can be similar to symptoms of Covid-19, last about a day and are more likely to occur after the second dose. Early reports from vaccine trials suggest that some people may need to take a day off because they feel lousy after receiving the second dose. In the Pfizer study, around half developed fatigue. Other side effects occurred in at least 25 to 33 percent of patients, sometimes more, including headache, chills, and muscle pain. While these experiences are not pleasant, they are a good sign that your own immune system is having a strong response to the vaccine that provides lasting immunity.
    • Will mRNA vaccines change my genes? No. Moderna and Pfizer vaccines use a genetic molecule to boost the immune system. This molecule, known as mRNA, is eventually destroyed by the body. The mRNA is packaged in an oily bubble that can fuse with a cell, allowing the molecule to slide inside. The cell uses the mRNA to make proteins from the coronavirus that can stimulate the immune system. At any given moment, each of our cells can contain hundreds of thousands of mRNA molecules that they produce to make their own proteins. As soon as these proteins are made, our cells use special enzymes to break down the mRNA. The mRNA molecules that our cells make can only survive a few minutes. The mRNA in vaccines is engineered to withstand the cell’s enzymes a little longer, so the cells can make extra viral proteins and trigger a stronger immune response. However, the mRNA can hold for a few days at most before it is destroyed.

Eric Mamer, a spokesman for the European Commission, declined to comment on the price list as the negotiated agreements were “kept confidential” but did not contest the pricing.

A spokeswoman for Ms De Bleeker said she tweeted the details to settle a political debate in Belgium in which opposition officials accuse the government of not providing enough money to buy the vaccines.

“We tried to be transparent, but it seems we were a little too transparent,” said Bavo De Mol, the spokesman.

Several health economists have found that the price of the vaccine itself – even if the US is paying more than Europe – is trivial compared to the economic cost of an ongoing pandemic. Just this week, Congress is preparing to approve payments of $ 600 to each American adult to cushion the blow of the pandemic-sparked recession, far more than the $ 39 per person required are to vaccinate adults at the higher Pfizer price.

“The cost of overpayment is so small compared to potential counterfactual factors,” said Benedic Ippolito, an American Enterprise Institute-based researcher who studies drug prices. “It’s like a shrug when our price is a little higher. This is a one-time pandemic and we will deal with the drug price situation later. “

Categories
Health

LG to launch robotic that disinfects surfaces amid coronavirus pandemic

LG Electronics is working on an autonomous robot that uses ultraviolet light to disinfect what the South Korean tech giant calls “high-touch, high-traffic areas”.

In an announcement this week, LG announced it would roll out the technology to retail, education, hospitality and corporate customers in the United States beginning early next year.

In a statement, Roh Kyu-chan, Head of Robots at LG’s Business Solutions Company, said, “This autonomous UV robot comes at a time when hygiene is a top priority for hotel guests, students and restaurant customers.”

“Customers in the contactless ecosystem we are facing now will expect a higher level of hygiene,” said Roh.

According to LG, its robot will use UV-C light. There are three main types of UV radiation: UV-A, UV-B and UV-C.

The US Food and Drug Administration has described the latter as “a well-known disinfectant for air, water and non-porous surfaces”.

Regarding the current pandemic, the FDA notes that there is currently “limited published data on the wavelength, dose, and duration of UVC radiation required to inactivate the SARS-CoV-2 virus”.

For many people around the world, concerns about cleanliness and hygiene have increased due to the coronavirus pandemic. There is also debate within the scientific community about the risk of inanimate object transmission.

The US Centers for Disease Control and Prevention said on their website, “It is possible that a person could get COVID-19 by touching a surface or object that has the virus on and then their own Touches her mouth, her own nose, or her own eyes. “

However, it adds, “COVID-19 is not believed to spread to touching surfaces.” Most commonly, the virus spreads through close contact between people, according to the CDC.

LG Electronics is one of many large organizations and companies developing technologies that focus on UV-C as a disinfectant.

In October, Transport for London announced that over 200 devices that use ultraviolet light to disinfect surfaces will be installed on London’s extensive underground network.

TfL said the technology will be deployed on the handrails of 110 escalators over a period of several weeks.

According to the transport body, the device uses a “small dynamo” to generate electricity from the movement of the handrail, which in turn powers the UV lamp that is used to disinfect its surface.

Signify – a major player in the lighting industry – is now offering a so-called “desk lamp” for sale in selected Asian countries. The “lamp” can be used to disinfect rooms in houses.

Look no hands

While some are turning to UV light to address concerns about cross-contamination and virus spread, others are trying to put in place systems that could alter the way you physically interact with public spaces.

Even before the pandemic, movement-activated taps and toilets were introduced in heavily frequented transport hubs such as train stations and airports.

GEZE UK, which specializes in technologies related to doors, windows and security, committed itself to the bathroom issue at the beginning of this month and declared that it had developed a so-called “hands-free toilet door kit”.

The system, which uses sensors and is based on “contactless activation”, can be connected to the outside communal door of a public toilet.

This ensures that “those who leave the washroom do not have to touch the door after washing their hands”.

Categories
World News

Financial institution of England holds charges regular as coronavirus outlook stays unsure

A woman wearing a protective face mask crosses the street in front of the Bank of England in the normally morning rush hour in the City of London on March 17, 2020. The UK’s financial district is unusually quiet after the government asked People who were yesterday by Refrain from all but essential travel and activities.

Jonathan Perugia

LONDON – The UK’s central bank kept its monetary policy stance unchanged on Thursday as much of the country enters the holiday season under the highest level of coronavirus restrictions.

The Bank of England kept its main lending rate at 0.1% after slashing from 0.75% twice since the pandemic broke out in March, and kept its target inventory of asset purchases at £ 895 billion ($ 1.2 trillion) ).

At its last meeting in November, the Monetary Policy Committee (MPC) agreed to expand its bond purchases as England entered a month-long national lockdown amid a resurgence of Covid-19 cases.

In Thursday’s report, the MPC noted that successful testing and initial launch of vaccines is likely to reduce the downside risk to the economic outlook identified in November.

“Still, recent global activity has been influenced by the increase in Covid cases and the associated reintroduction of restrictions,” the report said.

“The UK-weighted global GDP growth in the fourth quarter of 2020 is likely to be slightly weaker than expected at the time of the November report.”

Data released last week showed that the UK’s economic recovery nearly stalled in October before tighter measures were taken. According to data from Johns Hopkins University, the country has one of the highest fatalities in Europe, with 65,618 deaths and more than 1.9 million cases as of Thursday morning.

It has also suffered the biggest economic blow, with GDP (gross domestic product) falling and an unprecedented 19.8% in the second quarter.

The bank noted that despite the surge in cases and the lockdown measures that came with it, recent activity has been stronger than expected. However, it was found that the restrictions put in place after the lockdowns were lifted were more severe than expected and are expected to weigh on activity in the first quarter of 2021.

“The outlook for the economy remains unusually uncertain. It will depend on how the pandemic develops and public health measures, as well as the nature and transition to the new trade agreements between the European Union and the UK.” “The MPC said in the report it will monitor the situation closely and be ready to act if the inflation outlook weakens.

UK 12-month CPI (consumer price index) inflation fell from 0.7% in October to 0.3% in November, well below the bank’s 2% target.

“Waiting stuck”

“Just as the Federal Reserve is waiting for news of an economic stimulus package, the Bank of England is waiting for a solution to the Brexit negotiations and has therefore decided to put further stimulus packages on hold,” said Hinesh Patel, portfolio manager at Quilter Investors. in a research report.

“It seems that the BoE are paralyzed by the outcome of a Brexit deal but are still conscious as they try to adjust where they can.”

Patel added that with much of the country in the highest level of Covid restrictions, the bank is on “wait mode” before responding to further economic threats and will remain as accommodative as it has been year round.

Laith Khalaf, financial analyst at AJ Bell, agreed that the bank will not take its next step until it knows which direction Brexit is going.

“In the event of a no-deal, it would likely be ready to weather the temporary surge in inflation resulting from the weaker sterling and the imposition of tariffs, but it couldn’t ignore the economic impact of a disruption.” Brexit, “he said.

“The bank’s governor has stated that no deal would have a greater economic impact than the pandemic in the long term. Therefore, if the Brexit talks fail, we can expect further incentives, either in the form of more QE (quantitative easing) or rate cuts.”

Categories
Health

Putin calls on public to take the coronavirus vaccine

Russian President Vladimir Putin spoke on screen during his annual press conference on December 17, 2020 in Moscow.

Mikhail Svetlov | Getty Images News | Getty Images

Russia’s President Vladimir Putin urged the public to receive the coronavirus vaccine but said he has not yet received it himself.

At his annual press conference in December on Thursday, Putin encouraged Russians to take the Sputnik V vaccine and said he would receive it as soon as he was able.

“Our health care professionals say the vaccines … are for people of certain ages … people like me are not allowed to take vaccines yet. I’m a law abiding citizen and I always listen to what our health care professionals say, that’s why I haven’t been vaccinated yet, but I will certainly do that as soon as it is allowed. “

“Our vaccine is effective and safe, so I see no reason why we should be afraid of getting a shot,” he said, adding that Russia’s priority is to vaccinate its own citizens and increase its manufacturing capacity this.

Sputnik V has been tested on volunteers aged 18 to 60 years and is therefore only recommended for people between these age groups. Since Putin is 68 years old, he does not qualify.

The Russian direct investment fund, which supports the Russian vaccine, said Thursday that a separate study will be conducted in the age group over 60 to see if it is “safe and efficient” for the elderly.

Vaccinating the elderly, and especially those with underlying health needs, is considered a priority by most experts as they are the most susceptible to dying from Covid-19. In the UK, where the Pfizer BioNTech vaccine is already being made available to the public, the elderly and health care workers are the first to receive it.

Attempts in over 60 years

The Russian news agency Tass reported in October that the first group of volunteers aged 60 and over had been vaccinated with the Russian Sputnik V, which was attended by a total of 110 people.

The first group of volunteers had 28 members, including people with chronic conditions common to the elderly, such as diabetes, high blood pressure and chronic kidney failure. The oldest person in the group was 82, Tass reported.

The chief researcher of the Central Clinical Hospital of Russia, Nikita Lomakin, who leads the studies, said no negative reactions were observed in the first group.

Later in October, the head of the Federal Research Center for Epidemiology and Microbiology in Gamaleya said people over 60 will develop Covid antibodies after being vaccinated, but they may be less effective than those produced by younger people.

“The vaccination has definitely started, a certain number of people aged 60, 70, maybe even 80 years of age have been vaccinated,” said Alexander Gintsburg of Gamaleya, Tass reported. “We don’t expect anything out of the ordinary, there won’t be any additional side effects, they’ll develop antibodies. The only thing is to what extent the antibodies neutralize the virus: younger people develop antibodies that interact very well with the virus, while older people develop antibodies that a lot.” interact less with the virus – dozens or even hundreds of times less. “

Categories
Business

One Wild Mink Close to Utah Fur Farms Exams Optimistic for the Coronavirus

A wild mink in Utah tested positive for the coronavirus. Mink on fur farms in the area became infected with the virus, and the U.S. Department of Agriculture, along with other government agencies, tested wildlife for possible infections that could spread from those farms.

The division reported the case to the World Organization for Animal Health, noting that it appeared to be the first wild animal to naturally become infected with the virus that has infected mink in a number of fur farms around the world.

The virus has spread from people to mink and in some cases back again. A mutant strain of the virus that jumped back to humans from the mink caused Denmark to kill all of its mink and wiped out a large industry. No further evidence has supported initial concerns that the mutated variant of the virus might affect the usefulness of vaccines, but scientists are still concerned about how easily the virus can spread on mink farms.

“This is an important reminder that farm (and human) resorting to wildlife is also a real thing and needs to be on our radar,” said Jonathan Epstein, vice president of science and outreach for the EcoHealth Alliance, of the positive test in wild mink. Dr. Epstein and other scientists and conservationists have warned of the possibility that the coronavirus could establish itself in some wildlife species.

ProMed, an information site for the International Society for Infectious Diseases, published a note from Thomas DeLiberto and Susan Shriner of the Department of Agriculture’s Animal and Phytosanitary Inspection Service describing the test results.

They said that the positive test showed a virus with the same genome that had been found in infected mink, but that a test did not mean the virus was now spreading in the wild. “There is currently no evidence that SARS-CoV-2 was circulated or established in wild populations around the infected mink farms. Several animals from different wild animal species were sampled, all the others tested negative, ”the statement said.

“Finding a virus in a wild mink but not in other nearby wildlife likely indicates an isolated event, but we should take all of this information seriously,” said Tony L. Goldberg of the University of Wisconsin School of Veterinary Medicine -Madison. He added, “Controlling viruses in humans is ultimately the best way to prevent them from spreading to animals.”

Categories
Health

Did You Get the Coronavirus Vaccine, or Are You Planning To?

With the approval of the Food and Drug Administration, Pfizer is shipping doses of its coronavirus vaccine to hospitals across the country this week.

Health care workers have already started taking the pictures and most nursing home residents will have them next week. Other priority groups – likely a combination of key workers, people aged 65 and over, and people at high risk for disease – are expected to gain access sometime in January.

The New York Times reporters writing about the vaccine would like to hear – or try – your experience with the vaccine. We also want to know if receiving a vaccine changes your daily behavior or your attitudes about going out in public and interacting with others.

We will not publish any part of your submission without contacting you first.

Required fields are marked with an asterisk.